GENE ONLINE|News &
Opinion
Blog

R&D
R&D Genome
‘Junk DNA’ May Provide New Treatment for Neurological Disorders
2022-10-13
R&D GlioblastomaCancer Research
Activating Cryptochrome Isoforms May Inhibit Glioblastoma Proliferation, Providing New Therapeutic Possibilities
2022-10-07
R&D Oncology
Shutting Down Backup Genes Could Provide Key to Targeted Cancer Therapies
2022-10-07
R&D Flu
Researchers Uncover Possible Link Between Flu Vaccine and Stroke Protection
2022-10-04
R&D Synthetic Biologics
Bacteria-Derived Protocells Mark Breakthrough in Synthetic Biology
2022-09-23
R&D CAR-T Cell
Overcoming Immune Evasion in CAR-T Therapies with Groundbreaking New Discoveries
2022-09-22
R&D Targeted Therapy
Promising CHIP Protein Could Act as ‘Molecular Switch’ to Longevity
2022-09-21
R&D human embryos
Is Frozen-Thawed Embryo Transfer Associated with Increased Cancer Risk?
2022-09-16
R&D Cancer Research
Lactate’s Potential is an Immunotherapy Supplement for Cancer Treatments
2022-09-12
R&D Tuberculosis
UNC Chapel Hill Research on Long Release Drugs for Fighting Tuberculosis
2022-09-12
Technology MesotheliomaCheckpoint Inhibitor
Implantable “Drug Factory” Eradicates Mesothelioma in Mice When Combined with a Checkpoint Inhibitor
2022-09-06
R&D Glioblastoma
Injectable Hydrogel Targets Macrophages and Stops the Relapse of Glioblastoma
2022-09-06
Trials & Approvals Stem Cell Therapy
First U.S. Patient With Dry AMD Receives Autologous Stem Cell Therapy
2022-09-02
Chromosome
First Sustainable Chromosome Changes in Mammals
2022-09-01
R&D Huntington's Disease
Human Skin Cells Reprogramming Creates New Neurodegenerative Model For Huntington’s Disease
2022-08-31
1 … 6 7 8 9 10 … 34
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top